石四药集团：取得国家药监局有关别嘌醇片的药品生产注册批件

Group 1 - The company, Shijiazhuang Fourth Pharmaceutical Group, announced on September 1 that it has obtained the drug production registration certificate from the National Medical Products Administration for Allopurinol Tablets (0.1g), classified as a Class 3 chemical drug, which is considered to have passed the consistency evaluation [2] - Allopurinol Tablets are primarily used for the treatment of primary or secondary gout patients, patients undergoing treatment for leukemia, lymphoma, and malignant tumors, as well as for the treatment of recurrent calcium oxalate stone patients [2]